Floatz logo

Luminomark Inj. 0.

Indocyanine Green (ICG)

Seoul St. Mary's HospitalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Indocyanine Green (ICG) cohort.

Same molecule, other indications

Luminomark Inj. 0. is also rated in:

colorectal cancerDormant
D
Indicative ·
26 / 100
View asset →
colon carcinomaDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →